Page 205 - Effective healthcare cost containment policies Using the Netherlands as a case study - Niek W. Stadhouders

General Discussion
Brekke, K. R., Gravelle, H., Siciliani, L., and Straume, O. R. (2014). Patient choice, mobility and competition among health care providers. In "Health care provision and patient mobility", pp. 1- 26. Springer.
Brereton, L., and Vasoodaven, V. (2010). The impact of the NHS market. An overview of.
Britto-Arias, M., Waldmann, E., Jeschek, P., Gessl, I., Sallinger, D., Bannert, C., Weber, M., Trauner, M., Weiss, W., Ferlitsch, A., and Ferlitsch, M. (2015). Forceps versus snare polypectomies in colorectal cancer screening: Are we adhering to the guidelines? In "Endoscopy", Vol. 47, pp. 898-
902.
Brown, L. D. (2003). Comparing health systems in four countries: lessons for the United States. American
Journal of Public Health 93, 52-56.
Brownlee, S., Chalkidou, K., Doust, J., Elshaug, A. G., Glasziou, P., Heath, I., Nagpal, S., Saini, V.,
Srivastava, D., Chalmers, K., and Korenstein, D. (2017). Evidence for overuse of medical services
around the world. The Lancet 390, 156-168.
Buchanan, D. R. (2011). Should People with Unhealthy Lifestyles Pay Higher Health Insurance Premiums?
The Journal of Primary Prevention 32, 17-21.
Bundorf, M. K. (2016). Consumer-Directed Health Plans: A Review of the Evidence. Journal of Risk and
Insurance 83, 9-41.
Burns, L. R., and Pauly, M. V. (2018). Transformation of the Health Care Industry: Curb Your Enthusiasm?
The Milbank Quarterly 96, 57-109.
Burns, M. E. (2009). Medicaid managed care and cost containment in the adult disabled population.
Medical Care 47, 1069-1076 8p.
Busse, R., and Blümel, M. (2014). "Germany: Health system review." European Observatory on Health
Systems and Policies.
Busse, R., Geissler, A., and Quentin, W. (2011). "Diagnosis-Related Groups in Europe: Moving towards
transparency, efficiency and quality in hospitals," McGraw-Hill Education (UK).
Busse, R., Petrakova, A., and Prymula, R. (2001). Implementing hospital reforms in the Czech Republic.
EUROHEALTH-LONDON- 7, 29-31.
Cassel, C. K., and Guest, J. A. (2012). Choosing wisely: helping physicians and patients make smart
decisions about their care. Jama 307, 1801-1802.
CBS (2010-2015). Gezondheidsenquête. (CBS, ed.).
CBS (2016). CBS Statline. Vol. 2016, http://statline.cbs.nl/statweb.
CBS (2018). Gezonde levensverwachting/Healthy life expectancy. (C. S. Netherlands, ed.),
https://opendata.cbs.nl/statline/#/CBS/nl/dataset/71950ned/table?ts=1520501206321.
Chandra, A., Cutler, D., and Song, Z. (2012). Who ordered that? The economics of treatment choices in
medical care. Handbook of health economics 2, 397-432.
Chandra, A., Finkelstein, A., Sacarny, A., and Syverson, C. (2016). Health care exceptionalism?
performance and allocation in the us health care sector. American Economic Review 106, 2110-44. Checkland, K., Dam, R., Hammond, J., Coleman, A., Segar, J., Mays, N., and Allen, P. (2018). Being autonomous and having space in which to act: commissioning in the ‘new NHS’in England.
Journal of social policy 47, 377-395.
Checkland, K., Harrison, S., Snow, S., Mcdermott, I., and Coleman, A. (2012). Commissioning in the
English National Health Service: what's the problem? Journal of Social Policy 41, 533-550.
Chen, W.-Y., Liang, Y.-W., and Lin, Y.-H. (2017). Does Health Spending Crowd out Defense in the United
States? Evidence from Wavelet Multiresolution Analysis. Defence and Peace Economics, 1-14. Chernew, M., DeCicca, P., and Town, R. (2008). Managed Care and Medical Expenditures of Medicare
Beneficiaries. Journal of Health Economics 27, 1451-1461.
Chernew, M. E., Baicker, K., and Hsu, J. (2010). The Specter of Financial Armageddon — Health Care and
Federal Debt in the United States. New England Journal of Medicine 362, 1166-1168.
Chevreul, K., Berg Brigham, K., Durand-Zaleski, I., and Hernández-Quevedo, C. (2015). "France: Health
system review," European Observatory on Health Systems and Policies.
CIBG (2007-2014). Jaarverantwoording in de zorg (DigiMV). (CIBG, ed.), Den Haag.
Claxton, K. (2008). Exploring Uncertainty in Cost-Effectiveness Analysis. PharmacoEconomics 26, 781-
798.
Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., Devlin, N., Smith, P. C., and
Sculpher, M. (2015a). Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health technology assessment (Winchester, England), 1- 542.
197